{"id":"https://openalex.org/W2417508342","doi":"https://doi.org/10.12788/j.sder.2016.006","title":"Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence","display_name":"Topical Therapies for Psoriasis: Improving Management Strategies and Patient Adherence","alternate_titles":[],"publication_year":2016,"publication_date":"2016-03-01","ids":{"openalex":"https://openalex.org/W2417508342","doi":"https://doi.org/10.12788/j.sder.2016.006","mag":"2417508342","pmid":"https://pubmed.ncbi.nlm.nih.gov/27074696"},"language":"en","primary_location":{"id":"doi:10.12788/j.sder.2016.006","doi":"https://doi.org/10.12788/j.sder.2016.006","is_oa":false,"landing_page_url":"https://doi.org/10.12788/j.sder.2016.006","pdf_url":null,"source":{"id":"https://openalex.org/S183739505","display_name":"Seminars in Cutaneous Medicine and Surgery","issn_l":"1085-5629","issn":["1085-5629","1558-0768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4322696809","host_organization_name":"Frontline Medical Communications","host_organization_lineage":["https://openalex.org/P4322696809"],"host_organization_lineage_names":["Frontline Medical Communications"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Cutaneous Medicine and Surgery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2417508342"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048521405","display_name":"Linda Stein Gold","orcid":"https://orcid.org/0000-0002-2758-1605","observed_orcids":["https://orcid.org/0000-0002-2758-1605"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Linda F Stein Gold","raw_affiliation_strings":["Director of Dermatology Research Henry Ford Health System Detroit, Michigan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director of Dermatology Research Henry Ford Health System Detroit, Michigan","institution_ids":["https://openalex.org/I154057602"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5048521405"],"corresponding_institution_ids":["https://openalex.org/I154057602"],"apc_list":null,"apc_paid":null,"fwci":2.4368,"has_fulltext":false,"cited_by_count":75,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.8844609,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"35","issue":"2S","first_page":"S36","last_page":"S44"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9829999804496765},{"id":"https://openalex.org/keywords/topical-therapy","display_name":"topical treatment","score":0.972000002861023},{"id":"https://openalex.org/keywords/corticosteroids","display_name":"corticosteroids","score":0.8370000123977661},{"id":"https://openalex.org/keywords/vitamin-d-derivatives","display_name":"vitamin D derivatives","score":0.9480000138282776},{"id":"https://openalex.org/keywords/calcipotriol","display_name":"calcipotriol","score":0.9150000214576721},{"id":"https://openalex.org/keywords/betamethasone-dipropionate","display_name":"betamethasone dipropionate","score":0.9179999828338623},{"id":"https://openalex.org/keywords/tazarotene","display_name":"tazarotene","score":0.925000011920929},{"id":"https://openalex.org/keywords/anthralin","display_name":"anthralin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.9980000257492065},{"id":"https://openalex.org/keywords/pimecrolimus","display_name":"pimecrolimus","score":1.0},{"id":"https://openalex.org/keywords/patient-adherence","display_name":"patient adherence","score":0.8059999942779541},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.47699999809265137},{"id":"https://openalex.org/keywords/patient-expectations","display_name":"patient expectations","score":0.5},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.8069999814033508}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9499163627624512},{"id":"https://openalex.org/C2779306117","wikidata":"https://www.wikidata.org/wiki/Q3981685","display_name":"Tazarotene","level":3,"score":0.80780029296875},{"id":"https://openalex.org/C2779800615","wikidata":"https://www.wikidata.org/wiki/Q4897349","display_name":"Betamethasone dipropionate","level":3,"score":0.7654162049293518},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7343617677688599},{"id":"https://openalex.org/C2776028589","wikidata":"https://www.wikidata.org/wiki/Q417489","display_name":"Pimecrolimus","level":4,"score":0.6850131154060364},{"id":"https://openalex.org/C2781463552","wikidata":"https://www.wikidata.org/wiki/Q419397","display_name":"Dithranol","level":3,"score":0.5106666684150696},{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.49849796295166016},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4833528697490692},{"id":"https://openalex.org/C2778496887","wikidata":"https://www.wikidata.org/wiki/Q341500","display_name":"Acitretin","level":3,"score":0.4634065628051758},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4537031352519989},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.43819957971572876},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4006879925727844},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.17898699641227722},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.08056390285491943},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.07884931564331055}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000875","descriptor_name":"Anthralin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001623","descriptor_name":"Betamethasone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001623","descriptor_name":"Betamethasone","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002117","descriptor_name":"Calcitriol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005938","descriptor_name":"Glucocorticoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009539","descriptor_name":"Nicotinic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012720","descriptor_name":"Severity of Illness Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014677","descriptor_name":"Pharmaceutical Vehicles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014807","descriptor_name":"Vitamin D","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016559","descriptor_name":"Tacrolimus","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017410","descriptor_name":"Practice Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.12788/j.sder.2016.006","doi":"https://doi.org/10.12788/j.sder.2016.006","is_oa":false,"landing_page_url":"https://doi.org/10.12788/j.sder.2016.006","pdf_url":null,"source":{"id":"https://openalex.org/S183739505","display_name":"Seminars in Cutaneous Medicine and Surgery","issn_l":"1085-5629","issn":["1085-5629","1558-0768"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4322696809","host_organization_name":"Frontline Medical Communications","host_organization_lineage":["https://openalex.org/P4322696809"],"host_organization_lineage_names":["Frontline Medical Communications"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in Cutaneous Medicine and Surgery","raw_type":"journal-article"},{"id":"pmid:27074696","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27074696","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in cutaneous medicine and surgery","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W14769339","https://openalex.org/W74634963","https://openalex.org/W207408096","https://openalex.org/W1538534197","https://openalex.org/W1560654611","https://openalex.org/W1601145807","https://openalex.org/W1607014686","https://openalex.org/W1965679398","https://openalex.org/W1976459566","https://openalex.org/W1977250321","https://openalex.org/W1984327073","https://openalex.org/W2010624460","https://openalex.org/W2010757272","https://openalex.org/W2017957916","https://openalex.org/W2020555111","https://openalex.org/W2023239918","https://openalex.org/W2026429348","https://openalex.org/W2026798970","https://openalex.org/W2027199021","https://openalex.org/W2043413139","https://openalex.org/W2045940178","https://openalex.org/W2054692050","https://openalex.org/W2057114249","https://openalex.org/W2058832375","https://openalex.org/W2075016651","https://openalex.org/W2083822655","https://openalex.org/W2099706116","https://openalex.org/W2100105332","https://openalex.org/W2108935504","https://openalex.org/W2128551077","https://openalex.org/W2131364029","https://openalex.org/W2153121082","https://openalex.org/W2156864427","https://openalex.org/W2157527537","https://openalex.org/W2157600223","https://openalex.org/W2163990719","https://openalex.org/W2166793660","https://openalex.org/W2203996567","https://openalex.org/W2345379764","https://openalex.org/W2400081979","https://openalex.org/W2430705130","https://openalex.org/W2742484040"],"related_works":["https://openalex.org/W2756615787","https://openalex.org/W1584039499","https://openalex.org/W4312113486","https://openalex.org/W14298789","https://openalex.org/W2104220203","https://openalex.org/W1964487329","https://openalex.org/W1569925044","https://openalex.org/W2294876669","https://openalex.org/W2944711121","https://openalex.org/W1969134027"],"abstract_inverted_index":{"Psoriasis":[0],"is":[1,75],"a":[2,7,55,94,149],"chronic":[3],"disease":[4],"that":[5,72,164],"has":[6],"substantial":[8],"effect":[9],"on":[10],"quality":[11],"of":[12,14,37,41,57,64,82,116],"life":[13],"patients":[15,70,168],"and":[16,34,51,69,84,104,109,123,130,133,157,160],"often":[17],"needs":[18],"long-term":[19],"treatment.":[20],"Topical":[21],"treatments":[22,43,103],"for":[23,54,93,140],"psoriasis":[24],"include":[25],"corticosteroids,":[26],"vitamin":[27],"D":[28],"derivatives,":[29],"tazarotene,":[30],"anthralin,":[31],"tacrolimus,":[32],"pimecrolimus,":[33],"newer":[35],"formulations":[36],"tar.":[38],"Although":[39],"many":[40],"these":[42],"are":[44,90,165],"effective,":[45],"they":[46],"must":[47],"be":[48,67,97,148],"prescribed":[49],"appropriately":[50],"used":[52],"consistently":[53],"period":[56],"weeks":[58],"to":[59,88,96,144,167],"months":[60],"before":[61],"clinical":[62],"evidence":[63],"improvement":[65],"can":[66,147,169],"seen":[68],"perceive":[71],"the":[73,137,153],"treatment":[74,95,138,146,154,162,172],"working.":[76],"As":[77],"such,":[78],"medication":[79,89],"dosage/schedule,":[80],"choice":[81],"vehicle,":[83],"especially":[85],"patient":[86,100,117],"adherence":[87,143],"key":[91],"factors":[92],"effective.":[98],"Addressing":[99],"preferences":[101],"about":[102,106],"concerns":[105],"treatment-related":[107],"toxicities":[108],"managing":[110],"their":[111],"expectations":[112],"represent":[113],"additional":[114],"aspects":[115],"care.":[118],"Therapies":[119],"such":[120],"as":[121],"calcipotriene":[122],"betamethasone":[124],"dipropionate":[125],"(Cal/BD)":[126],"fixed":[127],"combination":[128],"foam":[129],"new":[131,159],"drugs":[132],"vehicles":[134,163],"continuously":[135],"enhance":[136],"landscape":[139],"psoriasis.":[141],"Because":[142],"topical":[145],"major":[150],"difficulty,":[151],"keeping":[152],"regimen":[155],"simple":[156],"using":[158],"sophisticated":[161],"acceptable":[166],"likely":[170],"improve":[171],"outcomes.":[173]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2417508342","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
